Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-018256
Filing Date
2025-10-16
Accepted
2025-10-16 08:21:05
Documents
50
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 832605
2 EX-31.1 ex31-1.htm EX-31.1 18295
3 EX-32.1 ex32-1.htm EX-32.1 5784
  Complete submission text file 0001493152-25-018256.txt   3266702

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pulm-20250930.xsd EX-101.SCH 24297
5 XBRL CALCULATION FILE pulm-20250930_cal.xml EX-101.CAL 36226
6 XBRL DEFINITION FILE pulm-20250930_def.xml EX-101.DEF 76317
7 XBRL LABEL FILE pulm-20250930_lab.xml EX-101.LAB 202342
8 XBRL PRESENTATION FILE pulm-20250930_pre.xml EX-101.PRE 151153
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 404144
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 251396433
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)